Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Anesth Analg ; 104(1): 204-6, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17179272

RESUMEN

We present a patient who underwent pulmonary lobectomy with thoracic epidural analgesia and developed postoperative sensory-motor symptoms of the lower limbs. Radiological investigation indicated ischemia of the conus medullaris as the likely cause. The motor deficit disappeared gradually and the patient was mobilizing independently when discharged on postoperative day 21.


Asunto(s)
Adenocarcinoma/cirugía , Analgesia Epidural , Neoplasias Pulmonares/cirugía , Procedimientos Quirúrgicos Torácicos/efectos adversos , Anciano , Antihipertensivos/uso terapéutico , Arteriosclerosis , Estudios de Seguimiento , Humanos , Hipertensión/tratamiento farmacológico , Masculino , Fumar
2.
Anesth Analg ; 94(4): 830-4, table of contents, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11916780

RESUMEN

UNLABELLED: One-lung ventilation (OLV) induces an increase in pulmonary shunt sometimes associated with a decrease in PaO2 despite ventilation with 100% oxygen. PaO2 improvement has been reported in one-lung ventilated animals receiving IV almitrine, a pulmonary vasoconstrictor. We evaluated the ability of almitrine to prevent a decrease in PaO2 during OLV. Patients without pulmonary hypertension undergoing OLV for lung surgery were randomly assigned to receive either placebo (Group P, n = 8) or almitrine infusion at a rate of 8 microg x kg(-1) x min(-1) (Group A, n = 8) from the start of OLV. Gasometric and hemodynamic values were recorded with the patient in the lateral decubitus position during two-lung ventilation and at 10-min intervals during OLV over a 30-min period (OLV-10, OLV-20, OLV-30). Compared with the values found during two-lung ventilation (434 +/- 22 mm Hg in Group P and 426 +/- 23 mm Hg in Group A), PaO2 decreased at OLV-10 (305 +/- 46 mm Hg), OLV-20 (203 +/- 20 mm Hg), and OLV-30 (178 +/- 18 mm Hg) in Group P (P < 0.05) and at OLV-20 (354 +/- 25 mm Hg) and OLV-30 (325 +/- 17 mm Hg) in Group A (P < 0.05). PaO2 values differed between the groups at OLV-20 and OLV-30 (P < 0.05). Pulmonary artery pressure and cardiac output did not change. In conclusion, 8 microg x kg(-1) x min(-1) IV almitrine prevents and limits the OLV-induced decrease in PaO2 without causing any hemodynamic modification. IMPLICATIONS: Eight microg x kg(-1) x min(-1) IV almitrine limits one-lung ventilation-induced decrease in PaO2 without causing any hemodynamic modification in patients without pulmonary hypertension.


Asunto(s)
Almitrina/administración & dosificación , Hemodinámica/efectos de los fármacos , Oxígeno/sangre , Neumonectomía , Respiración Artificial , Fármacos del Sistema Respiratorio/administración & dosificación , Presión Sanguínea/efectos de los fármacos , Dióxido de Carbono/sangre , Método Doble Ciego , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Circulación Pulmonar/efectos de los fármacos , Respiración Artificial/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA